SGC-2085

CAS No. 1821908-48-8

SGC-2085( SGC2085 | SGC 2085 )

Catalog No. M12811 CAS No. 1821908-48-8

SGC-2085 is a potent, selective protein arginine methyltransferase PRMT4 (CARM1) inhibitor with IC50 of 50 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 215 In Stock
10MG 323 In Stock
25MG 534 In Stock
50MG 777 In Stock
100MG 1071 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SGC-2085
  • Note
    Research use only, not for human use.
  • Brief Description
    SGC-2085 is a potent, selective protein arginine methyltransferase PRMT4 (CARM1) inhibitor with IC50 of 50 nM.
  • Description
    SGC-2085 is a potent, selective protein arginine methyltransferase PRMT4 (CARM1) inhibitor with IC50 of 50 nM, displays >100-fold selectivity over other PRMTs (PRMT6 IC50=5.3 uM); also shows complete selectivity against a panel of 21 human protein methyltransferases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SGC2085 | SGC 2085
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    CARM1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1821908-48-8
  • Formula Weight
    312.4061
  • Molecular Formula
    C19H24N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 32 mg/mL
  • SMILES
    CC1=CC(=CC(=C1)OC2=C(C=C(C=C2)CNC(=O)C(C)N)C)C
  • Chemical Name
    Propanamide, 2-amino-N-[[4-(3,5-dimethylphenoxy)-3-methylphenyl]methyl]-, (2S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ferreira de Freitas R, et al. J Med Chem. 2016 Jul 28;59(14):6838-47.
molnova catalog
related products
  • MI-503

    A highly potent and orally bioavailable small-molecule inhibitor of Menin-MLL interaction with Kd of 9.3 nM.

  • EPZ6438

    EPZ-6438 is a potent, and selective EZH2 inhibitor with Ki and IC50 of 2.5 nM and 11 nM in cell-free assays.

  • NV03

    NV03 is a small-molecule antagonist of the H3K9me3 binding to UHRF1 tandem tudor domain with Kd of 2.4 uM.